Results 181 to 190 of about 5,167 (211)
Some of the next articles are maybe not open access.
Fibroid management in premenopausal women
Climacteric, 2019Uterine fibroids are the most common tumors affecting premenopausal women, responsible for bleeding, pain, and reduced quality of life. When symptomatic, their management mainly involves surgery, which is all too often radical (hysterectomy). While surgical options sparing the uterus (hysteroscopic and laparoscopic myomectomy) and other non-surgical ...
J. Donnez, G. E. Courtoy, M.-M. Dolmans
openaire +3 more sources
Premenopausal Osteoporosis: How to Treat?
Reumatología Clínica (English Edition), 2012There is no agreement in defining osteoporosis in premenopausal women and diagnosis must be done carefully and not based on densitometric parameters. One must take into account the presence of other risk factors and history of fragility fractures, diseases or drugs that cause bone loss.
Melania, Martínez-Morillo +2 more
openaire +2 more sources
Minerva medica, 2008
While osteoporosis is a major public health concern, guidelines for diagnosis and treatment of low bone mass in the premenopausal population is lacking. Dual-energy x-ray absorptometry (DEXA) is a poor diagnostic tool to evaluate bone density in this population and the World Health Organization's definition of osteoporosis based on DEXA is not ...
L, Bischoff, C T, Derk
openaire +1 more source
While osteoporosis is a major public health concern, guidelines for diagnosis and treatment of low bone mass in the premenopausal population is lacking. Dual-energy x-ray absorptometry (DEXA) is a poor diagnostic tool to evaluate bone density in this population and the World Health Organization's definition of osteoporosis based on DEXA is not ...
L, Bischoff, C T, Derk
openaire +1 more source
Idiopathic osteoporosis in premenopausal women
Osteoporosis International, 2004Although osteoporosis predominantly affects older postmenopausal women, low bone mineral density also occurs in men and younger women. In men, it is often unexplained by recognized secondary causes. These men with idiopathic osteoporosis have reductions in serum IGF-I as well as indices of reduced bone formation. Younger women also experience bone loss
Mishaela R, Rubin +6 more
openaire +2 more sources
Premenopausal bleeding associated with hyperprolactinaemia
Maturitas, 1995A sample of 54 climacteric women (mean age 48.1 years) being treated for premenopausal bleeding was assessed. The mean serum prolactin value was 23.04 ng/ml. A separate group of 28 hyperprolactinaemic patients showing a mean level of 34.43 mg/ml was compared. No abnormalities of the sella turcica at skull X-ray examination were disclosed.
E, Ratchev, S, Dokumov
openaire +2 more sources
Premenopausal hysterectomy and cardiovascular disease
American Journal of Obstetrics and Gynecology, 1981A premenopausal simple hysterectomy is associated with a threefold increase in the subsequent incidence and prevalence of coronary heart disease during the remaining premenopausal years. During the 10 years following a premenopausal hysterectomy, there is an approximately 4% probability of developing coronary heart disease and a 0.4% probability of ...
openaire +2 more sources
Osteoporosis in premenopausal women
Medicina Clínica (English Edition)The development of osteoporosis and fractures in young premenopausal women is infrequent and is usually associated with secondary causes of osteoporosis. Therefore, it is recommendable to perform a clinical evaluation and a thorough laboratory study searching for possible causes of bone loss in these patients.
openaire +2 more sources
Tamoxifen and Premenopausal Breast Cancer
Annals of Internal Medicine, 1988Excerpt To the Editor:In his excellent review (1) of tamoxifen in the treatment of breast cancer, Legha concludes that "adjuvant use of tamoxifen in premenopausal women with stage II breast cancer ...
openaire +2 more sources
1990
In the context of discussions on hormone replacement after the menopause, the title “Premenopausal hormone therapy” may seem a contradiction in terms. It may appear illogical to administer exogenous oestrogen while a woman’s ovaries are still producing endogenous hormones. Premenopausal hormone therapy, however, is in widespread use.
openaire +1 more source
In the context of discussions on hormone replacement after the menopause, the title “Premenopausal hormone therapy” may seem a contradiction in terms. It may appear illogical to administer exogenous oestrogen while a woman’s ovaries are still producing endogenous hormones. Premenopausal hormone therapy, however, is in widespread use.
openaire +1 more source

